Tumor tissue sections showed increased infiltration of CD8+ T cells and NK cells in the treatment groups, with the most pronounced immune cell infiltration in the combination treatment group and a 1.5-fold increase in anti-tumor cytotoxicity. The gene discussed is CD8A; the disease is neoplasm.